GPT and metabolic dysfunction-associated steatotic liver disease: By measuring the serum AST and ALT levels in NAFLD mice (Figure 3A,B), we found that compared with the control group, the model group mice developed a certain degree of liver damage, which was manifested by clearly increased serum AST and ALT levels.